biotechnology
-
Rejuvenate Bio CEO highlights ambitious approach of using gene therapy to reverse aging
CEO and Co-founder Daniel Oliver share how he and his co-founder started the company and their vision for treating age-related conditions.
-
Biotech falls short on diversity in workplace, exec teams, according to report
BIO’s first annual report on diversity in the workplace found room for improvement, as biotech workforces – especially at the executive level – were found to not represent the U.S. population. The report was based on a survey of nearly 100 companies in late spring 2019.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
A decade after biosimilars pathway’s creation, FDA issues final interchangeability rules
The rules are still more restrictive than the European Medicines Agency’s, which allow national governments to determine interchangeability. The FDA would require additional testing to demonstrate products can be freely substituted like generic pharmaceuticals.
-
MedCity News launches biopharma-focused newsletter
The biotech century has arrived, and it’s consequently now more important than ever for us to highlight our coverage of biopharma.
-
Biopharma startup financing had strong showing in 2018, report shows
The report, by PitchBook, shows figures consistent with a similar report earlier this month by Silicon Valley Bank, which forecast more M&A deals this year.
-
Bristol-Myers Squibb to acquire Celgene in $74B deal
The acquisition brings together two of the largest drugmakers in the country, both of which are major players in biopharma, particularly oncology.
-
Blockchain becomes a ‘source of truth’ for biopharma
Although blockchain faces regulatory hurdles and skepticism, its potential as a shared, yet secure ledger system to improve the pharmaceutical supply chain integrity and clinical trials is making it attractive for experimentation and investment by drugmakers.
-
TraceLink raises $93 million in Series D financing round
The company’s life sciences track-and-trace network reaches drugmakers, pharmacies and others, with a customer base of more than 930 companies.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
How will millennials shape the future of the biotech industry?
In many ways, the biotech field is the healthcare equivalent to the Millennial generation.
-
How Biotech Is Revolutionizing Personalized Medicine
In 2005, my late father gave a lecture at Stanford University discussing personalized nutrition for […]
-
3 Biotech Trends That Will Change the World
I don’t know about you, but sometimes I think the latest biotechnology developments were ripped […]
-
Morning Read: Illumina partners with investors to launch digital hub for genomics
Illumina has partnered with Warburg Pincus and Sutter Hill Ventures to create digital hub Helix for consumers to obtain genetic tests and complementary services from third parties.
-
As more tech companies enter healthcare, developing clinical trial software poses as many risks as rewards
Taking on clinical trials adds another dimension to the healthIT challenge.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
